Zofran (odansetron) was approved by the US Food and Drug Administration in 1991 for the prevention of nausea and vomiting resulting from chemotherapy and radiation and for prevention of postoperative nausea and vomiting. Studies of Zofran have never been done in pregnant women, so the label warns the consumer that although studies of the drug… Read More